The Natus Suzhou facility opened on October 27, 2026, expanding the medical-device company’s local development and manufacturing capabilities in China. The opening follows the September launch of its first product manufactured and sold in the country.

Key Takeaways

  • The Suzhou site builds the Nicolet EDX electrodiagnostic system for the Chinese market.
  • China’s National Medical Products Administration approved the locally manufactured device on June 18, 2026.

Natus Suzhou facility supports local production

Natus Medical said the facility brings together development, production, quality and technical support teams. The company intends to develop products closer to clinicians and manufacture them closer to patients in China.

Natus said healthcare procurement in China increasingly prioritizes locally manufactured medical technologies. The company did not disclose the size or cost of its investment in the facility.

First locally made device launched in September

The Nicolet EDX was the first locally manufactured Natus product registered in China, after receiving final regulatory approval in June. It launched in September and is manufactured and sold in the country.

The system supports nerve conduction studies and electromyography and evoked-potential studies. Clinicians use the information it collects to help diagnose neuromuscular diseases and conditions.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.